| NCT ID | NCT01803282 |
| Title | Safety and Tolerability Study in Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | yes |
| Sponsors | Gilead Sciences |
| Indications |
gastroesophageal junction adenocarcinoma |
| Therapies |
Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab |
| Age Groups: | adult senior |